Stockreport

Launch of Phase 3 clinical trial with Nefecon in Japan

Calliditas Therapeutics AB - American Depositary Shares  (CALT) 
PDF STOCKHOLM, July 4, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ STOCKHOLM: CALTX) ("Calliditas") today announces that its partner Viatris Pharm [Read more]